ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0A4Y Aim Immunotech Inc

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aim Immunotech Inc 0A4Y London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% -
Open Price Low Price High Price Close Price Previous Close
more quote information »

Recent News

Date Time Source Heading
3/26/202408:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
3/25/202408:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
3/07/202407:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
2/29/202407:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
2/14/202407:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
1/24/202408:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
1/22/202407:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
1/10/202407:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
11/27/202308:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
11/15/202306:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
11/09/202307:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
10/17/202307:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
9/11/202312:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
8/15/202305:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
8/09/202308:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
8/08/202307:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
7/18/202318:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
7/10/202307:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
6/27/202310:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
6/27/202307:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..
4/12/202307:35GLOBEAIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W...
4/03/202305:30GLOBEAIM ImmunoTech Reports Fourth Quarter and Full Year 2022..

Your Recent History

Delayed Upgrade Clock